PicnicHealth focuses on managing digital health records and supporting medical research. The company collects and digitizes patients' medical records, organizing them into a user-friendly timeline that helps individuals track their health history and share it with healthcare providers. Additionally, users can choose to contribute their anonymized medical data to research initiatives, aiding in the advancement of medical science. Unlike many competitors, PicnicHealth combines personal health management with contributions to research, creating a dual benefit for users and the medical community. The goal is to empower patients in managing their health while facilitating breakthroughs in medicine through data sharing.

Felicis

Amplify Partners

Slow Ventures

Scott Marlette

Paul Buchheit

Inevitable Ventures

Jameson Hsu

Sam Lessin

Ramji Srinivasan

Kenny Van Zant

Joe Greenstein

Rishi Kacker

Refactor Capital

Social Capital Partners

Eric Evans

Great Oaks Venture Capital

Wonder Ventures

Rashmi Sinha

B Capital Group

Biotechnology

Healthcare

Picnic Health

SAN DIEGO, June 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Diurnal Ltd., a Neurocrine Biosciences company, presented information from its neuroendocrinology pipeline at the Endocrine Society Annual Meeting, ENDO 2024, including primary data just published in The New England Journal of Medicine from its CAHtalyst™ Phase 3 registrational studies of crinecerfont in pediatric and adult patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. In addition, Neurocrine Biosciences presented CAHtalog™ Registry data regarding the negative impact of high glucocorticoid (GC) doses and natural history in pediatric and adult CAH patients, as well as disease- and GC-related comorbidities data in CAH patients."We were thrilled to share our just published primary CAHtalyst Phase 3 data with ENDO 2024 attendees this past weekend," said Eiry W. Roberts, M.D., Chief Medical Officer at Neurocrine Biosciences. "Crinecerfont offers the potential of a long-awaited new treatment paradigm for endocrinologists in managing CAH. Our CAHtalyst Phase 3 data demonstrate the potential of crinecerfont to reduce elevated androgen levels and lower supraphysiologic glucocorticoid doses while maintaining androgen control in CAH patients of four years and older."CAHtalystTM Phase 3 Pediatric and Adult DataIn an oral presentation on June 1, Richard Auchus, M.D., Principal Investigator, Professor of Pharmacology and Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan, presented CAHtalyst Phase 3 Adult data demonstrating that the study met its primary and important key secondary endpoints, with 63% of crinecerfont-treated participants achieving reduction in GC dosing to physiologic range (≤ 11mg/m2/day) while maintaining androstenedione control at Week 24 as compared with just 18% with placebo control participants

Neurocrine Biosciences Presented Cahtalyst™ Phase 3 Pediatric And Adult Studies, Cahtalog™ Registry And Disease- And Glucocorticoid-Related Comorbidities Data In Cah At Endo 2024

Company's leading AI-driven platform simplifies observational research and gives patients complete access to all their medical records and health informationSAN FRANCISCO, May 16, 2024 /PRNewswire/ -- PicnicHealth today announced it was ranked among the World's Best Digital Health Companies by Newsweek and named the "Best MedTech Startup" by MedTech Breakthrough. PicnicHealth's AI-driven platform is radically simplifying observational research and enabling life science companies to meet their study endpoints faster and with full transparency.PicnicHealth enables a fundamentally different approach to observational research by directly consenting patients and rapidly accessing all their past and future medical records from across the country. To date, PicnicHealth has curated more than 32 million patient records across over 40 disease areas, given over 33,000 patients access to their records, and helped 12 of the 20 largest life sciences companies meet their research endpoints."We're proving that technology and AI can efficiently capture high-quality insights across patients' journeys to run more efficient and comprehensive studies for life sciences," said Troy Astorino, co-founder and CTO of PicnicHealth. "Congratulations to the team for the major impact they're driving on research and healthcare outcomes through patient-centric data."Newsweek Ranks PicnicHealth Among World's Best 43 Companies for Health RecordsPicnicHealth was one of only 43 technology companies in the health records market segment to make the inaugural Newsweek and Statista ranking of World's Best Digital Health Companies 2024. The list identified the digital services and technologies transforming the healthcare industry, highlighting the 400 leading innovative companies based in 35 countries in seven industry segments, including digital platforms for storing, managing, and sharing electronic health records and patient information securely. Learn more about the list methodology here .MedTech Breakthrough Names PicnicHealth the Best MedTech Startup in 2024PicnicHealth was recognized as "Best MedTech Startup" in the seventh annual MedTech Breakthrough Awards, led by an independent market intelligence organization, MedTech Breakthrough, that recognizes the top companies, technologies, and products in the global digital health and medical technology market

Picnichealth Earns Honors As Top Health Technology Company From Newsweek And Medtech Breakthrough

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely.

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

- PicnicHealth, a platform that simplifies medical records and provides actionable health insights, has unveiled a new AI assistant designed to empower patients in managing their healthcare.

PicnicHealth Launches AI Assistant to Empower Patients

What You Should Know:– PicnicHealth, a platform that simplifies medical records and provides actionable health insights, has unveiled a new AI assistant designed to empower patients in managing their healthcare.– PicnicHealth’s AI assistant helps patients navigate the complexities of the healthcare system and make informed decisions about their health.Simplifying Healthcare NavigationMany patients, especially those with chronic conditions, struggle to keep track of their medical records, which are often scattered across various providers and patient portals. PicnicHealth addresses this challenge by integrating health data from any U.S. care site, creating a centralized and comprehensive view of a patient’s medical history.PicnicHealth’s AI Assistant key features include:AI Search: Patients can ask questions about their health history and receive AI-powered answers with links to relevant data sources within their medical records.Patients can ask questions about their health history and receive AI-powered answers with links to relevant data sources within their medical records. Smart Pinboards: Patients can track specific health conditions, such as diabetes or cancer, with personalized pinboards that organize related medical information.Patients can track specific health conditions, such as diabetes or cancer, with personalized pinboards that organize related medical information. Smart Highlights: Provides instant explanations of complex medical terms within the context of a patient’s health records.Empowering Patients with InformationPicnicHealth’s AI assistant empowers patients to:Understand their health history: Access and easily review their complete medical records.Access and easily review their complete medical records. Track their care: Monitor their health conditions and treatments with personalized pinboards.Monitor their health conditions and treatments with personalized pinboards

Picnichealth Launches Ai Assistant To Empower Patients

Pulse leverages a direct-to-patient approach and a leading AI technology platform to make more efficient and comprehensive observational studies a realitySAN FRANCISCO, June 4, 2024 /PRNewswire/ -- PicnicHealth , a company radically simplifying observational research, launched its Pulse product today to enable high-quality, low-burden research for life sciences companies and patients. Pulse does this by going directly to consented patients, accessing their longitudinal medical record, and capturing study data through a single, adaptable platform. By cutting through many inefficient layers and systems that burden traditional observational research, Pulse helps life science companies meet study endpoints faster and with full transparency."Pulse strengthens the quality of evidence generation, both in terms of clinical and patient impact, by supporting more comprehensive data collection and making it more enticing for patients to participate in studies," said Nancy A. Dreyer, chief scientific advisor to PicnicHealth. "I'm excited to see the future of observational research evolve with Pulse."The proprietary AI behind Pulse enables a fundamentally different approach to observational research. PicnicHealth directly consents patients and then rapidly accesses all of their past and future medical records from across the country

Picnichealth Launches Pulse Product To Simplify Observational Research

PicnicHealth launches Clinical Services to enhance care management.

PicnicHealth Launches Clinical Services to Enhance Care Management

SAN FRANCISCO, Aug. 6, 2024 /PRNewswire/ - Today, PicnicHealth, a company dedicated to simplifying observational research, announced the appointment of Jennifer Stacey as chief delivery officer.

Jennifer Stacey Joins PicnicHealth as Chief Delivery Officer

Previously restricted by outdated study models, complete data capture is now an efficient and flexible option using cutting-edge technologies, including artificial intelligence (AI)

Evidence Unlocked: How Ai And Technology Is The Key To More Robust Observational Research, Upcoming Webinar Hosted By Xtalks

CAHtalyst™ Pediatric Study Baseline Characteristics Data Highlight Need for Novel Treatments in Children and Adolescents with Congenital Adrenal Hyperplasia (CAH)CAHtalog™ Registry Data of Glucocorticoid Treatment Patterns in Pediatric and Adult Patients Illustrates the Challenges of Long-Term CAH ManagementSAN DIEGO, May 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today presented the CAHtalyst™ Pediatric Phase 3 clinical study baseline characteristics data for children and adolescents with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency enrolled in the study, along with CAHtalog™ Registry data assessing glucocorticoid treatment patterns in pediatric and adult patients with CAH.These data demonstrate the limitations of current CAH treatment approaches in pediatric patients, comorbidities associated with the condition and/or current treatment, including obesity, advanced bone age, and early puberty, and the difficulty in managing the disease effectively as CAH patients age into adults. These new data were presented at the Pediatric Endocrine Society 2024 Annual Meeting in Chicago.CAHtalyst Phase 3 Pediatric Study Baseline CharacteristicsBaseline characteristics of the subjects who enrolled in the CAHtalyst Pediatric Phase 3 study were presented (Poster# 56). The study enrolled 103 subjects 4 to 17 years of age with a medically confirmed diagnosis of CAH due to 21-hydroxylase deficiency, with 52% male, mean age 12 years old, and majority in Tanner stages 3-5. There was evidence indicating inadequate adrenal androgen control in many of these patients despite supraphysiologic glucocorticoid dosing. At baseline, more than a third of the participants reported comorbidities of advanced bone age, early puberty, and obesity

Neurocrine Biosciences Presented Cahtalyst™ Pediatric Study Baseline Characteristics And Cahtalog™ Registry Data At Pes 2024

Digitizes and organizes patient medical records

Picnic Health

Digitizes and organizes patient medical records

Picnic Health

Digitizes and organizes patient medical records

About

Simplify's Take

What believers are saying

What critics are saying

What makes Picnic Health unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Picnic Health is Hiring for 0 Jobs on Simplify!